Programmed cell death (PCD) is an ordered and tightly controlled set of cha
nges in gene expression and protein activity that results in neuronal cell
death during brain development. This article reviews the molecular pathways
by which PCD is executed in mammalian cells and the potential relation of
these pathways to pathologic neuronal cell death. Whereas the classical pat
terns of apoptotic morphologic change often do not appear in the brain afte
r ischemia, there is emerging biochemical and pharmacologic evidence sugges
ting a role for PCD in ischemic brain injury. The most convincing evidence
for the induction of PCD after ischemia includes the altered expression and
activity in the ischemic brain of deduced key death-regulatory genes. Furt
hermore, studies have shown that alterations in the activity of these gene
products by peptide inhibitors, viral vector-mediated gene transfer. antise
nse oligonucleotides, or transgenic mouse techniques determine, at least in
part, whether ischemic neurons live or die after stroke. These studies pro
vide strong support for the hypothesis that PCD contributes to neuronal cel
l death caused by ischemic injury. However, many questions remain regarding
the precise pathways that initiate, sense, and transmit cell death signals
in ischemic neurons and the molecular mechanisms by which neuronal cell de
ath is executed at different stages of ischemic injury. Elucidation of thes
e pathways and mechanisms may lead to the development of novel therapeutic
strategies for brain injury after stroke and related neurologic disorders.